Expanded Access Program: Safety of Erythrocytes Encapsulating L-asparaginase (GRASPAÂ®) in Combination With Polychemotherapy in Patients Under 55 Years Old With Acute Lymphoblastic Leukemia (ALL) at Risk to Receive Other Formulation of Asparaginase